top of page
fidelis-bg-preview.png

About Us

Our 
Story

Get to Know Us

Fidelis Bio was started by passionate antibody, AI scientists  and engineers to dramatically reduce the time and cost to bring mab therapies to patients in need. We have backgrounds from leading pharmaceutical, biotech and academic institutions and understand the entire value chain for generating antibodies across therapeutics, diagnostics and research products. We bring our combined expertise in antibodies, AI, and technology to you to maximize your chance of success.

Built for Leading Scientists 

Best-in-class Platform

We leverage the latest technologies from biotechnology and combine them with advanced computing/AI and robotics to drive dramatic gains in mab discovery. 

Built by Scientists & Validated in the Lab

Our team brings an exceptional track record of having worked with all major pharmaceutical, biotechnology, and academic institutions over the years on antibody development. These include applications in therapeutics, diagnostics, and research projects globally. We understand all major aspects of antibody development so can bring all that expertise to you along with the latest technologies to maximize your program for success.

bottom of page